Iovance Biotherapeutics Announces Approval for TIL Therapy
…in combination with pembrolizumab compared with pembrolizumab alone in participants with untreated, advanced melanoma. The trial is enrolling participants with…
Iovance Biotherapeutics Announces Approval for TIL Therapy
…in combination with pembrolizumab compared with pembrolizumab alone in participants with untreated, advanced melanoma. The trial is enrolling participants with…
,
,
May is Brain Tumor Awareness Month
…to forget even hearing the words “brain metastases.” An estimated 7% to 10% of patients with melanoma develop brain metastases. These…
Book Suggestions for Caregivers
Supporting a loved one with melanoma can be a daunting journey. It often feels overwhelming. You are not only taking…
How Melanoma Cured Dylan Slattery
…called, he was told he had melanoma – a lethal form of skin cancer. Dylan emerged from surgery with a…
,
Immunocore’s Tebentafusp Successfully Activates T Cells Against Uveal Melanoma
…Drug Administration (FDA) and Promising Innovative Medicine (PIM) designation under the UK Early Access to Medicines Scheme. Uveal melanoma is…
,
,
Melanoma Survivor on Her Way To Princeton With Her Sights Set for the U.S. Olympic Team
…back and continuing to share her story. She’s chosen to partner with AIM at Melanoma for her senior project and…
,
Jim Zeoli Had Never Spent Much Time Thinking About Melanoma—Until He Was Diagnosed
by Mara Klecker Jim Zeoli had never spent much time thinking about melanoma before his own diagnosis at the end…
,
Celebrate Survivorship – Give Towards Melanoma Research
…studying the genetic makeup of melanoma, understanding disease progression, finding biomarkers, and developing new therapies. Together, we can make a…
,
May is Melanoma Awareneness Month
Welcome to May, a month dedicated to raising awareness about melanoma and skin cancer. At AIM at Melanoma, we’re committed…
A Life Rewritten: Finding Strength in the Face of Melanoma
By Mara Klecker Just Normal People Asked to describe his life before the first melanoma diagnosis—before losing an eye, undergoing…
,
Recent Posts
Mar. 26, 2026
Wade Watson, Stage III Melanoma Survivor: A Marathon, Not a Sprint
Mar. 03, 2026
Cancer is More Than a Diagnosis: Mind, Meaning, and Healing
Feb. 19, 2026
Merlin CP-GEP Becomes the First and Only Gene Expression Profile Test Recommended by NCCN®
Feb. 05, 2026
Best-in-Class Real-World Data Support Early Amtagvi® Treatment in Advanced Melanoma
Jan. 23, 2026